| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| Company: CADEX Genomics |
| Recipient: You |
| Company: Parithera |
| Recipient: You |
| Company: X genomes |
| Recipient: You |
| Company: OneCell Diagnostics India |
| Recipient: You |
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Checkmate Pharmaceuticals |
| Recipient: You |
| Company: Guardant Health |
| Recipient: You |
| Company: Foundation Medicine |
| Recipient: You |
| Company: Abbvie |
| Recipient: You |
| Company: Value Analytics Labs |
| Recipient: You |
| Company: Bayer |
| Recipient: You |
| Company: Taiho Oncology |
| Recipient: You |
| Company: Delcath |
| Recipient: You |
| Company: Seagen |
| Recipient: You |
| Company: CVS |
| Recipient: You |
| Company: SAGA Diagnostics |
| Recipient: You |
| Company: Illumina |
| Recipient: You |
| Company: UpToDate |
| Recipient: You |
| Company: Takeda |
| Recipient: You |
| Company: Astra Zeneca |
| Recipient: You |
| Company: Takeda |
| Recipient: You |
| Company: Pfizer |
| Recipient: You |
| Company: Xilio Therapeutics |
| Recipient: You |
| Company: GSK |
| Recipient: You |
| Company: Eli Lilly |
| Recipient: You |
| Company: MPM Capital |
| Recipient: You |
| Company: Merck |
| Recipient: You |
| Company: Amgen |
| Recipient: You |
| Company: Exact Sciences |
| Recipient: You |
| Company: Caris Life Sciences |
| Recipient: You |
| Company: Bristol-Myers Squibb |
| Recipient: You |
| Company: Incyte |
| Recipient: You |
| Company: Third Rock Ventures |
| Recipient: You |
| Company: Zola |
| Recipient: You |
| Company: Phesi |
| Recipient: You |
| Company: 3T BioSciences |
| Recipient: You |
| Company: DoMore Diagnostics |
| Recipient: You |
| Company: Summit pharmaceuticals |
| Recipient: You |
| Company: Regeneron |
| Recipient: You |
| Company: CareSet |
| Recipient: You |
| Company: Value Analytics Labs |
| Recipient: You |
| Company: Natera |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: PMV Pharma |
| Recipient: You |
| Company: Erasca, Inc |
| Recipient: You |
| Company: Syndax |
| Recipient: You |
| Company: Bristol-Myers Squibb |
| Recipient: Your Institution |
| Company: Genentech |
| Recipient: Your Institution |
| Company: Guardant Health |
| Recipient: Your Institution |
| Company: Array |
| Recipient: Your Institution |
| Company: Eli Lilly |
| Recipient: Your Institution |
| Company: Novartis Pharmaceuticals UK Ltd. |
| Recipient: Your Institution |
| Company: PureTech |
| Recipient: Your Institution |
| Company: Mirati Therapeutics |
| Recipient: Your Institution |
| Company: Daiichi Sankyo |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| Company: Karkinos |
| Recipient: You |
| Company: Karkinos |
| Recipient: You |
|
| Other Relationship |
| Company: C2i genomics |
| Recipient: You |
| Company: Xgenomes |
| Recipient: You |
| Company: Parithera |
| Recipient: You |
| Company: Cadex |
| Recipient: You |
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|